Literature DB >> 24257076

Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells.

Jennifer E Bruin1, Suheda Erener1, Javier Vela1, Xiaoke Hu1, James D Johnson2, Harley T Kurata3, Francis C Lynn2, James M Piret4, Ali Asadi1, Alireza Rezania5, Timothy J Kieffer6.   

Abstract

Human embryonic stem cells (hESCs) were used as a model system of human pancreas development to study characteristics of the polyhormonal cells that arise during fetal pancreas development. HESCs were differentiated into fetal-like pancreatic cells in vitro using a 33-day, 7-stage protocol. Cultures were ~90-95% PDX1-positive by day (d) 11 and 70-75% NKX6.1-positive by d17. Polyhormonal cells were scattered at d17, but developed into islet-like clusters that expressed key transcription factors by d33. Human C-peptide and glucagon secretion were first detected at d17 and increased thereafter in parallel with INS and GCG transcript levels. HESC-derived cells were responsive to KCl and arginine, but not glucose in perifusion studies. Compared to adult human islets, hESC-derived cells expressed ~10-fold higher levels of glucose transporter 1 (GLUT1) mRNA, but similar levels of glucokinase (GCK). In situ hybridization confirmed the presence of GLUT1 transcript within endocrine cells. However, GLUT1 protein was excluded from this population and was instead observed predominantly in non-endocrine cells, whereas GCK was co-expressed in insulin-positive cells. In rubidium efflux assays, hESC-derived cells displayed mild potassium channel activity, but no responsiveness to glucose, metabolic inhibitors or glibenclamide. Western blotting experiments revealed that the higher molecular weight SUR1 band was absent in hESC-derived cells, suggesting a lack of functional KATP channels at the cell surface. In addition, KATP channel subunit transcript levels were not at a 1:1 ratio, as would be expected (SUR1 levels were ~5-fold lower than KIR6.2). Various ratios of SUR1:KIR6.2 plasmids were transfected into COSM6 cells and rubidium efflux was found to be particularly sensitive to a reduction in SUR1. These data suggest that an impaired ratio of SUR1:KIR6.2 may contribute to the observed KATP channel defects in hESC-derived islet endocrine cells, and along with lack of GLUT1, may explain the absence of glucose-stimulated insulin secretion.
© 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257076     DOI: 10.1016/j.scr.2013.10.003

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  62 in total

1.  Effect of Sonic hedgehog pathway inhibition on PDX1 expression during pancreatic differentiation of human embryonic stem cells.

Authors:  Prasad S Pethe; Niloufer P Dumasia; Deepa Bhartiya
Journal:  Mol Biol Rep       Date:  2021-01-23       Impact factor: 2.316

Review 2.  Improving the physiological realism of experimental models.

Authors:  Kalyan C Vinnakota; Chae Y Cha; Patrik Rorsman; Robert S Balaban; Andre La Gerche; Richard Wade-Martins; Daniel A Beard; Jeroen A L Jeneson
Journal:  Interface Focus       Date:  2016-04-06       Impact factor: 3.906

Review 3.  Pancreas development in humans.

Authors:  Fong Cheng Pan; Marcela Brissova
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-04       Impact factor: 3.243

4.  Diabetes: β cells at last.

Authors:  Josué K Mfopou; Luc Bouwens
Journal:  Nat Rev Endocrinol       Date:  2014-11-11       Impact factor: 43.330

Review 5.  Advances and challenges in the differentiation of pluripotent stem cells into pancreatic β cells.

Authors:  Essam M Abdelalim; Mohamed M Emara
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

6.  V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells.

Authors:  Elisa Corritore; Yong-Syu Lee; Valentina Pasquale; Daniela Liberati; Mei-Ju Hsu; Catherine Anne Lombard; Patrick Van Der Smissen; Amedeo Vetere; Susan Bonner-Weir; Lorenzo Piemonti; Etienne Sokal; Philippe A Lysy
Journal:  Stem Cells Transl Med       Date:  2016-07-12       Impact factor: 6.940

7.  Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.

Authors:  Alireza Rezania; Jennifer E Bruin; Payal Arora; Allison Rubin; Irina Batushansky; Ali Asadi; Shannon O'Dwyer; Nina Quiskamp; Majid Mojibian; Tobias Albrecht; Yu Hsuan Carol Yang; James D Johnson; Timothy J Kieffer
Journal:  Nat Biotechnol       Date:  2014-09-11       Impact factor: 54.908

Review 8.  The quest to make fully functional human pancreatic beta cells from embryonic stem cells: climbing a mountain in the clouds.

Authors:  James D Johnson
Journal:  Diabetologia       Date:  2016-07-29       Impact factor: 10.122

Review 9.  Current stem cell based therapies in diabetes.

Authors:  Meredith A Lilly; Meghan F Davis; Josh E Fabie; Elizabeth B Terhune; G Ian Gallicano
Journal:  Am J Stem Cells       Date:  2016-10-20

10.  Identification of a small molecule that facilitates the differentiation of human iPSCs/ESCs and mouse embryonic pancreatic explants into pancreatic endocrine cells.

Authors:  Yasushi Kondo; Taro Toyoda; Ryo Ito; Michinori Funato; Yoshiya Hosokawa; Satoshi Matsui; Tomomi Sudo; Masahiro Nakamura; Chihiro Okada; Xiaotong Zhuang; Akira Watanabe; Akira Ohta; Nobuya Inagaki; Kenji Osafune
Journal:  Diabetologia       Date:  2017-05-22       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.